Hikal Ltd Faces Intensified Downtrend Amid Mixed Technical Signals

Current Price and Market Context

As of 6 Jan 2026, Hikal Ltd’s stock closed at ₹224.60, down 1.45% from the previous close of ₹227.90. The intraday range was relatively narrow, with a low of ₹223.65 and a high of ₹228.10. The stock is trading near its 52-week low of ₹217.35, significantly below its 52-week high of ₹456.60, reflecting a prolonged downtrend over the past year.

Comparatively, the Sensex has shown resilience, with a 1-year return of 7.85%, while Hikal has declined sharply by 43.54% over the same period. This divergence highlights sector-specific challenges and company-specific headwinds impacting Hikal’s performance.

Technical Trend Shift: From Mildly Bearish to Bearish

Recent technical assessments indicate a shift in Hikal’s trend from mildly bearish to outright bearish. This transition is underscored by several key indicators:

• Moving Averages (Daily): The daily moving averages remain bearish, with the stock price consistently trading below its short- and medium-term averages, signalling downward momentum.


• Bollinger Bands (Weekly & Monthly): Both weekly and monthly Bollinger Bands are bearish, suggesting increased volatility with a downward bias and potential continuation of the downtrend.


• MACD: The Moving Average Convergence Divergence (MACD) presents a mixed picture. While the weekly MACD is mildly bullish, indicating some short-term positive momentum, the monthly MACD remains bearish, reflecting longer-term weakness.

Momentum Indicators: RSI and KST

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral zones without indicating overbought or oversold conditions. This suggests a lack of strong directional momentum in the immediate term.

Conversely, the Know Sure Thing (KST) indicator offers a nuanced view: mildly bullish on the weekly timeframe but bearish on the monthly scale. This divergence implies that while short-term momentum may be attempting a recovery, the broader trend remains under pressure.

Volume and Trend Confirmation: OBV and Dow Theory

On-Balance Volume (OBV) analysis on both weekly and monthly charts shows no definitive trend, indicating that volume is not confirming any strong directional move. Similarly, Dow Theory assessments reveal no clear trend on either timeframe, suggesting market indecision or consolidation phases.

Mojo Score and Grade Update

MarketsMOJO has downgraded Hikal Ltd’s Mojo Grade from Sell to Strong Sell as of 14 Nov 2025, reflecting deteriorating fundamentals and technical outlook. The current Mojo Score stands at 12.0, signalling significant caution for investors. The Market Cap Grade remains low at 3, underscoring the company’s relatively modest market capitalisation within its sector.

Return Analysis: Underperformance Against Sensex

Hikal’s returns over various periods starkly contrast with the broader market benchmark, the Sensex:

• 1 Week: Stock down 1.06% vs Sensex up 0.88%


• 1 Month: Stock down 7.34% vs Sensex down 0.32%


• Year-to-Date: Stock down 1.01% vs Sensex up 0.26%


• 1 Year: Stock down 43.54% vs Sensex up 7.85%


• 3 Years: Stock down 44.99% vs Sensex up 41.57%


• 5 Years: Stock up 26.36% vs Sensex up 76.39%


• 10 Years: Stock up 101.86% vs Sensex up 234.01%

This persistent underperformance highlights structural challenges faced by Hikal, including sector headwinds and company-specific issues that have weighed on investor sentiment.

Implications for Investors

Given the prevailing bearish technical signals and the downgrade to Strong Sell, investors should exercise caution. The mixed signals from momentum indicators like MACD and KST suggest potential short-term rallies may occur, but the dominant monthly bearish trends and weak moving averages indicate that any such rallies could be limited and short-lived.

Investors with a long-term horizon may want to monitor for signs of trend reversal, particularly improvements in monthly MACD and RSI, alongside volume confirmation. Until then, the risk-reward profile remains skewed towards downside risk.

Sector and Industry Context

Within the Pharmaceuticals & Biotechnology sector, Hikal faces intense competition and regulatory challenges that have contributed to its subdued performance. The sector itself has shown mixed trends, with some companies benefiting from innovation and global demand, while others struggle with pricing pressures and pipeline delays.

Hikal’s technical deterioration relative to its peers suggests that investors may find better risk-adjusted returns elsewhere in the sector or in other industries with more favourable momentum and fundamentals.

Conclusion

Hikal Ltd’s recent technical parameter changes reveal a clear shift towards bearish momentum, reinforced by weak moving averages, bearish Bollinger Bands, and a downgraded Mojo Grade to Strong Sell. While short-term indicators like weekly MACD and KST offer mild bullish hints, the dominant monthly signals caution investors against expecting sustained rallies.

Given the stock’s significant underperformance relative to the Sensex and the Pharmaceuticals & Biotechnology sector, investors should approach Hikal with prudence, considering alternative opportunities with stronger technical and fundamental profiles.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →